Evidence map›Paper›PMID 27920476›Full record

ArticleWorld journal of gastroenterology2016

Self-expanding metal stents for the palliation of malignant gastric outlet obstruction in patients with peritoneal carcinomatosis.

Christoph Rademacher, Matthias Bechtler, Steffen Schneider, Bettina Hartmann, Johannes Striegel, Ralf Jakobs

Open access · hybridAbstract readComparative Study
In one paragraph

Article in World journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Christoph RademacherChristoph Rademacher, Matthias Bechtler, Bettina Hartmann, Johannes Striegel, Ralf Jakobs, Medizinische Klinik C, Klinikum der Stadt Ludwigshafen, 67063 Ludwigshafen, Germany.
Matthias BechtlerChristoph Rademacher, Matthias Bechtler, Bettina Hartmann, Johannes Striegel, Ralf Jakobs, Medizinische Klinik C, Klinikum der Stadt Ludwigshafen, 67063 Ludwigshafen, Germany.
Steffen SchneiderChristoph Rademacher, Matthias Bechtler, Bettina Hartmann, Johannes Striegel, Ralf Jakobs, Medizinische Klinik C, Klinikum der Stadt Ludwigshafen, 67063 Ludwigshafen, Germany.
Bettina HartmannChristoph Rademacher, Matthias Bechtler, Bettina Hartmann, Johannes Striegel, Ralf Jakobs, Medizinische Klinik C, Klinikum der Stadt Ludwigshafen, 67063 Ludwigshafen, Germany.
Johannes StriegelChristoph Rademacher, Matthias Bechtler, Bettina Hartmann, Johannes Striegel, Ralf Jakobs, Medizinische Klinik C, Klinikum der Stadt Ludwigshafen, 67063 Ludwigshafen, Germany.
Ralf JakobsChristoph Rademacher, Matthias Bechtler, Bettina Hartmann, Johannes Striegel, Ralf Jakobs, Medizinische Klinik C, Klinikum der Stadt Ludwigshafen, 67063 Ludwigshafen, Germany.
Klinikum Ludwigshafen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate the efficacy of self-expanding metal stents (SEMS) for the palliation of malignant gastric outlet obstruction in patients with and without peritoneal carcinomatosis (PC).

methodsWe performed a retrospective analysis of 62 patients who underwent SEMS placement for treatment of malignant gastroduodenal obstruction at our hospital over a six-year period. Stents were deployed through the scope under combined fluoroscopic and endoscopic guidance. Technical success was defined as successful stent placement and expansion. Clinical success was defined as an improvement in the obstructive symptoms and discharge from hospital without additional parenteral nutrition. According to carcinomatosis status, patients were assigned into groups with or without evidence of peritoneal disease.

resultsIn most cases, obstruction was caused by pancreatic (47%) or gastric cancer (23%). Technical success was achieved in 96.8% (60/62), clinical success in 79% (49/62) of all patients. Signs of carcinomatosis were identified in 27 patients (43.5%). The diagnosis was confirmed by pathology or previous operation in 7 patients (11.2%) and suspected by CT, MRI or ultrasound in 20 patients (32.2%). Presence of carcinomatosis was associated with a significantly lower clinical success rate compared to patients with no evidence of peritoneal disease (66.7%

conclusionGiven the limited therapeutic options and a clinical success rate of at least 66.7%, we believe that SEMS are a reasonable treatment option in patients with malignant gastric outlet obstruction with peritoneal carcinomatosis.

Indexed as

MetalsPalliative CareStentsAgedAged, 80 and overCarcinomaDuodenal ObstructionEndoscopy, GastrointestinalFemaleGastric Outlet ObstructionHumansMaleMiddle AgedPancreatic NeoplasmsPeritoneal NeoplasmsProsthesis DesignMetalsEndoscopyGastric outlet obstructionPalliationPeritoneal carcinomatosisSelf-expanding metal stents

Identifiers

PMID27920476
PMCPMC5116599
OpenAlexW2555204245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.